Henderson Jane
Insider CIK 1422304 · OPHT Director · EBIO Director · VYGR Sr. V.P. & CFO, Corp. Dev. · AKRO Director · LYCA Director · ADGI Chief Financial Officer · CRGX Director · APGE Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LYCA Lycia Therapeutics, Inc. | A Award deriv | 2026-10-22 | 2026-10-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 124,962 | — | $0 | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 175,345 | — | $0 | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 83,690 | — | $0 | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer | 2026-09-03 | 2026-09-03 | 158,371 | — | $0 | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 83,690 | — | — | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 124,962 | — | — | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 175,345 | — | — | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer | 2026-09-03 | 2026-09-03 | 158,371 | — | — | 0 | SEC↗ |
| LYCA Lycia Therapeutics, Inc. | A Award deriv | 2026-08-11 | 2026-10-26 | 57,666 | — | $0 | 57,666 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | G Gift | 2026-07-24 | 2026-07-24 | 15,000 | — | $0 | 158,371 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-05-01 | 2026-05-04 | 900 | $82.60 | $74.3K | 173,660 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-05-01 | 2026-05-04 | 811 | $81.02 | $65.7K | 174,560 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-05-01 | 2026-05-04 | 289 | $83.16 | $24.0K | 173,371 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-04-16 | 2026-04-17 | 2,000 | $90.00 | $180.0K | 175,371 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-04-01 | 2026-04-03 | 1,100 | $85.46 | $94.0K | 177,371 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-04-01 | 2026-04-03 | 900 | $84.46 | $76.0K | 178,471 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-03-25 | 2026-03-27 | 2,000 | $85.00 | $170.0K | 179,371 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-03-02 | 2026-03-04 | 406 | $71.66 | $29.1K | 181,371 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-03-02 | 2026-03-04 | 300 | $68.27 | $20.5K | 183,071 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-03-02 | 2026-03-04 | 994 | $70.45 | $70.0K | 181,777 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-03-02 | 2026-03-04 | 300 | $69.43 | $20.8K | 182,771 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-02-02 | 2026-02-04 | 100 | $66.89 | $6.7K | 183,371 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-02-02 | 2026-02-04 | 792 | $65.21 | $51.6K | 184,579 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-02-02 | 2026-02-04 | 1,108 | $66.15 | $73.3K | 183,471 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-01-06 | 2026-01-06 | 2,000 | $80.00 | $160.0K | 185,371 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 83,690 | — | $0 | 83,690 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-01-02 | 2026-01-06 | 1,920 | $74.13 | $142.3K | 191,451 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-01-02 | 2026-01-06 | 4,080 | $75.20 | $306.8K | 187,371 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-12-19 | 2025-12-23 | 1,500 | $80.00 | $120.0K | 193,371 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 11,797 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 13,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 13,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 26,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 9,398 | — | $0 | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-12-04 | 2025-12-05 | 1,500 | $75.00 | $112.5K | 194,871 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-11-25 | 2025-11-28 | 1,500 | $70.00 | $105.0K | 196,371 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-11-14 | 2025-11-14 | 2,000 | $65.00 | $130.0K | 197,871 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-11-11 | 2025-11-13 | 1,000 | $60.00 | $60.0K | 199,871 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | D To issuer deriv | 2025-08-19 | 2025-08-19 | 25,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-08-12 | 2025-08-12 | 3,000 | — | $0 | 11,797 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-08-12 | 2025-08-12 | 3,000 | $7.01 | $21.0K | 12,398 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-08-12 | 2025-08-12 | 3,000 | $47.46 | $142.4K | 9,398 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2025-06-03 | 2025-06-05 | 9,398 | — | $0 | 9,398 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | A Award deriv | 2024-12-09 | 2024-12-11 | 124,962 | — | $0 | 124,962 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-08-23 | 2024-08-23 | 6,000 | $48.26 | $289.6K | 200,871 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2024-06-08 | 2024-06-11 | 26,000 | — | $0 | 26,000 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | A Award deriv | 2024-06-04 | 2024-06-06 | 39,402 | — | $0 | 39,402 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | A Award deriv | 2024-06-04 | 2024-06-06 | 19,785 | — | $0 | 19,785 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | A Award deriv | 2023-12-18 | 2023-12-20 | 175,345 | — | $0 | 175,345 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 16,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 7,500 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 32,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 16,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 16,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 23,186 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 15,500 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer | 2023-07-11 | 2023-07-13 | 22,088 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2023-06-23 | 2023-06-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-06-16 | 2023-06-21 | 40,000 | — | $0 | 14,797 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-06-16 | 2023-06-21 | 22,498 | $54.46 | $1.23M | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-06-16 | 2023-06-21 | 40,000 | $7.01 | $280.4K | 40,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-06-16 | 2023-06-21 | 17,502 | $53.79 | $941.4K | 22,498 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2023-05-17 | 2023-05-19 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2023-05-11 | 2023-05-15 | 14,588 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2023-05-11 | 2023-05-15 | 14,588 | — | $0 | 22,088 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2022-05-12 | 2022-05-13 | 14,588 | — | $0 | 14,588 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2022-05-12 | 2022-05-13 | 23,186 | — | $0 | 23,186 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2022-05-11 | 2022-05-13 | 7,500 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2022-05-11 | 2022-05-13 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ADGI Adagio Therapeutics, Inc. | A Award deriv | 2022-01-30 | 2022-02-01 | 175,000 | — | $0 | 175,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2021-06-01 | 2021-06-03 | 13,000 | — | $0 | 13,000 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2021-05-19 | 2021-05-20 | 15,500 | — | $0 | 15,500 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2021-05-19 | 2021-05-20 | 7,500 | — | $0 | 7,500 | SEC↗ |
| SESN Sesen Bio, Inc. | A Award deriv | 2021-05-03 | 2021-05-10 | 92,500 | — | $0 | 92,500 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 16,000 | — | $0 | 16,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2020-06-01 | 2020-06-02 | 13,000 | — | $0 | 13,000 | SEC↗ |
| SESN Sesen Bio, Inc. | A Award deriv | 2020-05-06 | 2020-05-08 | 59,000 | — | $0 | 59,000 | SEC↗ |
| SESN Sesen Bio, Inc. | A Award deriv | 2019-06-19 | 2019-06-21 | 52,500 | — | $0 | 52,500 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2019-05-15 | 2019-05-16 | 16,000 | — | $0 | 16,000 | SEC↗ |
| SESN Sesen Bio, Inc. | A Award deriv | 2018-06-12 | 2018-06-14 | 52,500 | — | $0 | 52,500 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2018-05-23 | 2018-07-11 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | M Exercise deriv | 2018-03-23 | 2018-03-26 | 11,200 | — | $0 | 165,584 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | M Exercise | 2018-03-23 | 2018-03-26 | 11,200 | $11.97 | $134.1K | 11,200 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2018-03-23 | 2018-03-26 | 11,200 | $20.52 | $229.8K | 0 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | M Exercise deriv | 2018-03-22 | 2018-03-26 | 19,900 | — | $0 | 176,784 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2018-03-22 | 2018-03-26 | 19,900 | $21.07 | $419.3K | 0 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | M Exercise | 2018-03-22 | 2018-03-26 | 19,900 | $11.97 | $238.2K | 19,900 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | M Exercise deriv | 2018-03-19 | 2018-03-20 | 1,900 | — | $0 | 196,684 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | M Exercise | 2018-03-19 | 2018-03-20 | 1,900 | $11.97 | $22.7K | 1,900 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2018-03-19 | 2018-03-20 | 1,900 | $21.76 | $41.3K | 0 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | M Exercise deriv | 2018-03-16 | 2018-03-20 | 15,416 | — | $0 | 198,584 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2018-03-16 | 2018-03-20 | 15,416 | $22.15 | $341.5K | 0 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | M Exercise | 2018-03-16 | 2018-03-20 | 15,416 | $11.97 | $184.5K | 15,416 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2018-03-07 | 2018-03-09 | 65,000 | — | $0 | 65,000 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2018-01-13 | 2018-01-17 | 32,000 | — | $0 | 32,000 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | A Award deriv | 2017-05-19 | 2017-05-23 | 8,072 | — | $0 | 8,072 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2017-01-03 | 2017-01-05 | 214,000 | — | $0 | 214,000 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | A Award deriv | 2016-06-08 | 2016-06-10 | 8,072 | — | $0 | 8,072 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | A Award deriv | 2015-06-16 | 2015-06-18 | 8,072 | — | $0 | 8,072 | SEC↗ |